Influenza Diabetes Community

About the IDC

In October 2017 leading diabetes organisations and the European Scientific Working Group on Influenza (ESWI) joined forces to forge an active Influenza-Diabetes community (IDC) to raise awareness of the impact of influenza on people living with diabetes.

To keep the momentum going, annual work plans are adopted, including regular, quarterly meetings with invited guest lectures, overviews of recently published scientific articles and discussions and exchanges among Community members of best practices, campaigns, and webinars.

As a first work plan, the Influenza Diabetes Commitment Paper was adopted in 2019.

File Type Size
ESWI_fludiabetes_commitmentpaper.pdf Adobe Portable Document Format 569.5 KB

ESWI serves as its Secretariat and IDC is chaired by ESWI Board Member, Dr Marco Goeijenbier.  The IDC has been supported by Sanofi Pasteur since its inception.

Marco Goeijenbier
BIO
Marco Goeijenbier
ESWI Board member, Spaarne Hopital, The Netherlands

In 2021, new Vision and Mission statements were adopted in order to reflect the current COVID-19 pandemic and be more inclusive of other respiratory virus diseases, COVID-19 and RSV disease.

IDC’s vision and mission are as follows:

Optimal care for, and prevention of, respiratory virus infections in people living with diabetes.

Our vision

Our mission

To increase awareness, within the care community, of the burden of influenza, Covid-19 and RSV in people living with diabetes. To ensure access to care, and to ensure the translation of scientific data supporting clinical recommendations for effective protection from infection and disease, including non-pharmaceutical measures, vaccination and anti-viral treatment.